RxDoctor Payments Data

William Petrie, MD

Psychiatry · Nashville, TNNPI 1518945195

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Siemens Medical Solutions USA, Inc. accounts for 87.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $6,493 and has fallen 97.4% since, to $166 in 2025. Among psychiatry clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,409in general payments, 2019–2025

Across 16 payments — averaging $463.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$6K
  • Acadia Pharmaceuticals Inc$217
  • Sunovion Pharmaceuticals Inc.$213
  • E.r. Squibb & Sons, L.L.C.$146
  • Neurocrine Biosciences, Inc.$137
  • Teva Pharmaceuticals USA, Inc.$113
  • plus $90 from 1 others

What the payments were for

  • Consulting fees$4,05055%
  • Travel & lodging$2,26031%
  • Food & beverage$1,09915%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,409 in reported general payments places this provider in the 90th percentile of 503 psychiatry providers in Tennessee.

See all psychiatry providers in Tennessee

Medicare billing

Part B allowed, 2024
$31,678
Medicare patients
80
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate31$83,033
Clozapine208$29,223
OzempicSemaglutide12$12,324
TrintellixVortioxetine Hydrobromide12$8,296
Clomipramine Hcl31$4,016
Aripiprazole48$3,649
Fluoxetine Hcl62$1,698
Quetiapine Fumarate52$1,345
Mirtazapine28$995
Duloxetine Hcl62$942
Lithium Carbonate93$814
Bupropion XlBupropion Hcl28$774
Clonazepam56$747
Olanzapine18$732
Bupropion Hcl SrBupropion Hcl17$659

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCOlanzapine$90$73218 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 503 psychiatry providers in Tennessee.

Other psychiatry in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →